TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31218770

Group type: EXPERIMENTAL
Intervention: SVN-2B plus IFNβ
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: SVN-2B
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: SVN-2B plus IFNβ (Step 2)
Number of subjects: 83
Study: 29275607

Group type: EXPERIMENTAL
Intervention: Ketamine infusion (0.5 mg/kg in 250 ml of 0.9% normal saline for 1 hour daily for 7 days)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (0.9% normal saline infusion)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ketamine infusion
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study: 25010823

Group type: EXPERIMENTAL
Intervention: HME1L (Heat and Moisture Exchanger with low fresh gas flow 1 L·min)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HME3L (Heat and Moisture Exchanger with high fresh gas flow 3 L·min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1L (No Heat and Moisture Exchanger with low fresh gas flow 1 L·min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3L (No Heat and Moisture Exchanger with high fresh gas flow 3 L·min)
Number of subjects: 40
Study: 21870208

Group type: EXPERIMENTAL
Intervention: Percutaneous decompression (PD)
Number of subjects: 36
Study: 20137805

Group type: EXPERIMENTAL
Intervention: 8-week streptomycin (15 mg/kg once daily) and oral rifampicin (10 mg/kg once daily) for 8 weeks
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: 4-week streptomycin (15 mg/kg once daily) and oral rifampicin (10 mg/kg once daily) for 4 weeks followed by rifampicin and clarithromycin (7.5 mg/kg once daily) for 4 weeks
Number of subjects: 151
Study: 17645253

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with medication
Number of subjects: 60

Group type: COMPARATOR
Intervention: Simple acupuncture (Control Group I)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral administration of Bushen Capsules (Control Group II)
Number of subjects: 60
Study: 16098615

Group type: EXPERIMENTAL
Intervention: Isotonic Ems Mineral Salts (EMS) solution (1-2 sprays into each nostril t.d. for 14 days)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Xylometazoline solution (0.05%) (1-2 sprays into each nostril t.d. for 14 days)
Number of subjects: 66
Study: 11871957

Group type: EXPERIMENTAL
Intervention: Videotape feedback during simulations
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no videotape feedback)
Number of subjects: 32
Study: 10449020

Group type: COMPARATOR
Intervention: Water
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exceed
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Decarbonated Coca-Cola
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hypertonic solution of lactulose
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Physical maneuvers (bending forward, tightening abdominal muscles, tightening a belt, breathing through pursed lips)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Relaxing abdominal muscles or increasing the impact of foot strike
Number of subjects: 10
Study: 7595984

Group type: EXPERIMENTAL
Intervention: Electromyostimulation (EMS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Concentric exercise (CONC)
Number of subjects: 12
Study: 2220621

Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Mepindolol
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Beta blockers and enalapril
Number of subjects: 201
Study: 7194082

Group type: EXPERIMENTAL
Intervention: BAY g 5421 (3 x 100 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: BAY g 5421 (6 x 50 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Insulin, glucagon, lactate, triglyceride concentration (Control)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: BAY g 5421
Number of subjects: 10
Study: 31270901

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine
Number of subjects: 36

Group type: COMPARATOR
Intervention: 3% Sodium hypochlorite
Number of subjects: 36

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 36
Study: 29998767

Group type: EXPERIMENTAL
Intervention: Preservative-free latanoprost
Number of subjects: 140
Study: 28342682

Group type: EXPERIMENTAL
Intervention: 6-week home program comprising progressive resistance strength training, movement strategy training and falls education
Number of subjects: 133

Group type: COMPARATOR
Intervention: 6 weeks of non-specific life skills training (Control)
Number of subjects: 133
Study: 25431105

Group type: EXPERIMENTAL
Intervention: Positive airway pressure treatment (adherent patients)
Number of subjects: 822

Group type: COMPARATOR
Intervention: Positive airway pressure treatment (non-users)
Number of subjects: 822

Group type: COMPARATOR
Intervention: General population (n = 742)
Number of subjects: 822
Study: 23420314

Group type: EXPERIMENTAL
Intervention: Iontophoresis combined with local bath-PUVA therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Local PUVA therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Fluticasone (corticosteroid)
Number of subjects: 48
Study: 21276366

Group type: EXPERIMENTAL
Intervention: Wide-open group (hinge at the inner margin of the lateral mass)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Narrow-open group (hinge at the lamina margin)
Number of subjects: 102
Study: 19155203

Group type: EXPERIMENTAL
Intervention: Docetaxel in combination with doxorubicin and cyclophosphamide (TAC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-fluorouracil, doxorubicin and cyclophosphamide (FAC)
Number of subjects: 0
Study: 17382828

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 716
Study: 17173263

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis doses prescribed based on empirical criteria and urea kinetics model
Number of subjects: 0
Study: 12727944

Group type: EXPERIMENTAL
Intervention: Iopanoic acid (group A)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Glucocorticoids (group B)
Number of subjects: 12
Study: 10565811

Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cisplatin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (healthy volunteers)
Number of subjects: 16
Study: 8605634

Group type: EXPERIMENTAL
Intervention: Ramipril (an angiotensin-converting enzyme inhibitor)
Number of subjects: 9000

Group type: EXPERIMENTAL
Intervention: Vitamin E (a naturally occurring antioxidant vitamin)
Number of subjects: 9000
Study: 1835959

Group type: EXPERIMENTAL
Intervention: Candoxatril (200 mg) on low sodium diet (10 mmol/day)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Candoxatril (200 mg) on high sodium diet (350 mmol/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo on low sodium diet (10 mmol/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo on high sodium diet (350 mmol/day)
Number of subjects: 8
Study: 7104144

Group type: EXPERIMENTAL
Intervention: Propranolol (0.18 mg/kg i.v.)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pindolol (0.023 mg/kg i.v.)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31427299

Group type: EXPERIMENTAL
Intervention: VL-2397 (3 mg to 1,200 mg single intravenous doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VL-2397 (300, 600, and 1,200 mg intravenous doses every 24 hours for 7 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VL-2397 (single doses >30 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VL-2397 (overall and maximum exposures)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VL-2397 (safety profile)
Number of subjects: 0
Study: 30580349

Group type: EXPERIMENTAL
Intervention: Probiotics (lactobacillus rhamnosus 35) at a dose of 0.8 mg in infants >1500 gms and 0.4 mg in infants <1500 gms in 2 ml of expressed breast milk two times daily
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (expressed breast milk without probiotics)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Probiotics (lactobacillus rhamnosus 35)
Number of subjects: 72
Study: 25603000

Group type: EXPERIMENTAL
Intervention: Amoxicillin‐clavulanate (40mg/kg per day for 7 days)
Number of subjects: 84
Study: 23852661

Group type: EXPERIMENTAL
Intervention: Core decompression and isolated mononuclear cells (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Core decompression and unprocessed bone marrow injection (group B)
Number of subjects: 40
Study: 21245476

Group type: EXPERIMENTAL
Intervention: Electronic assisted consent (standard form-based informed consent plus a commercial interactive learning module)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard form-based informed consent
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Electronic assisted consent
Number of subjects: 101
Study: 19224775

Group type: EXPERIMENTAL
Intervention: 17beta‐estradiol
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study: 16846090

Group type: EXPERIMENTAL
Intervention: Electrical activation with 3 consecutive 40-/microsec pulses of 1.5 kV/cm direct electrical current in buffer solution
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no electrical activation)
Number of subjects: 100
Study: 14979308

Group type: EXPERIMENTAL
Intervention: Integrated care
Number of subjects: 23828

Group type: COMPARATOR
Intervention: Enhanced referral care
Number of subjects: 23828
Study: 10992303

Group type: EXPERIMENTAL
Intervention: 0.4 mmol/kg Gadovist 1.0
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 0.3 mmol/kg Gadovist 1.0
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 0.1 to 0.5 mmol/kg Gadovist 1.0
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Gadovist 1.0
Number of subjects: 89
Study: 9489070

Group type: EXPERIMENTAL
Intervention: Diclofenac sustained-released 75 mg tablets taken b.i.d.
Number of subjects: 294

Group type: COMPARATOR
Intervention: Diclofenac enteric-coated 50 mg tablets given t.i.d.
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Diclofenac sustained-released 75 mg tablets
Number of subjects: 294

Group type: COMPARATOR
Intervention: Diclofenac enteric-coated 50 mg tablets
Number of subjects: 294
Study: 8251281

Group type: EXPERIMENTAL
Intervention: Doxapram 1.5 mg kg‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pethidine 0.33 mg kg‐1
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 60
Study: 3885760

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 30283171

Group type: EXPERIMENTAL
Intervention: Oral melatonin 3 mg (2 tablets)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Oral alprazolam 0.25 mg (2 tablets)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (multivitamin tablet 2 tablets)
Number of subjects: 90
Study: 27376373

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) intravenous/subcutaneous
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etanercept (ETN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adalimumab (ADA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) subcutaneous
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) intravenous
Number of subjects: 0
Study: 24678896

Group type: EXPERIMENTAL
Intervention: CTC (Computed Tomography Colonography)
Number of subjects: 20000

Group type: COMPARATOR
Intervention: FS (Flexible Sigmoidoscopy)
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: CTC
Number of subjects: 20000

Group type: COMPARATOR
Intervention: FS
Number of subjects: 20000
Study: 24352089

Group type: EXPERIMENTAL
Intervention: Egg Breakfast (EB, n = 39)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Non-Egg Breakfast (NEB, n = 34)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Egg Breakfast (EB)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Non-Egg Breakfast (NEB)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 73
Study: 20595484

Group type: EXPERIMENTAL
Intervention: Topical nanofiber nitric oxide (NO) releasing patch (NOP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular meglumine antimoniate (Glucantime)
Number of subjects: 0
Study: 18381542

Group type: EXPERIMENTAL
Intervention: Multinutrient fortifier added to human milk for 12 weeks after discharge
Number of subjects: 39

Group type: COMPARATOR
Intervention: Unfortified human milk
Number of subjects: 39
Study: 16627409

Group type: EXPERIMENTAL
Intervention: Biventricular pacing (BVP)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Right ventricular pacing (RVP)
Number of subjects: 10
Study: 14732966

Group type: EXPERIMENTAL
Intervention: Combination of arnica and hydroxyethyl salicylate (HES) in ethanolic solution (Sportino Acute Spray)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Arnica
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydroxyethyl salicylate (HES)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ethanol (vehicle)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water (reference substance)
Number of subjects: 0
Study: 12799598

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation
Number of subjects: 28
Study: 10484218

Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Cholangiopancreatography (MRCP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Direct cholangiography (ERCP, PTC, intraoperative cholangiography)
Number of subjects: 100
Study: 7806733

Group type: EXPERIMENTAL
Intervention: Functional Status Questionnaire (FSQ)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Katz Activities of Daily Living (ADL)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Older Americans Resources and Services Instrumental Activities of Daily Living (OARS-IADL)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Physical Performance Test (PPT)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Medical Outcomes Study SF-36
Number of subjects: 83
Study: 1786052

Group type: EXPERIMENTAL
Intervention: Hyoscine (6 micrograms/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (4 micrograms/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 7154618

Group type: EXPERIMENTAL
Intervention: muzolimine (loop-diuretic) for 6 weeks
Number of subjects: 18
Study: 31337609

Group type: EXPERIMENTAL
Intervention: Sickle cell retinopathy (SCR) patients
Number of subjects: 52
Study: 30659924

Group type: EXPERIMENTAL
Intervention: Genotype-tailored lansoprazole daily for 24 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conventional dosing of open-label oral lansoprazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28487294

Group type: EXPERIMENTAL
Intervention: Platelets from high-responder donors
Number of subjects: 100

Group type: COMPARATOR
Intervention: Platelets from low-responder donors
Number of subjects: 100
Study: 26728633

Group type: EXPERIMENTAL
Intervention: SibworkS programme (six-week manual-based, cognitive-behavioural group programme)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: SibworkS programme
Number of subjects: 36
Study: 24002343

Group type: EXPERIMENTAL
Intervention: Exercise group (n = 28) completed a graded four-stage exercise protocol on a stationary bicycle (100 W × 5 min; 150 W × 5 min; 200 W × 5 min; sprint × 2 min)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (n = 14) tested at identical periods without exercising
Number of subjects: 42
Study: 21739168

Group type: EXPERIMENTAL
Intervention: Cilengitide 2000 mg i.v. twice weekly after surgery
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cilengitide 500 mg i.v. (day -8, -4, -1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cilengitide 2000 mg i.v. (day -8, -4, -1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cilengitide (as a single agent)
Number of subjects: 30
Study: 19409340

Group type: EXPERIMENTAL
Intervention: Early orthodontic treatment using Twin-block appliance
Number of subjects: 40

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 40
Study: 17443132

Group type: EXPERIMENTAL
Intervention: Zolpidem (7.5 mg) + Placebo (P)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg) or (500 mg) + Zolpidem (7.5 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo + Placebo (P+P)
Number of subjects: 6
Study: 15880649

Group type: EXPERIMENTAL
Intervention: Ultrasonic fundus-first dissection
Number of subjects: 80

Group type: COMPARATOR
Intervention: Electrocautery dissection from the triangle of Calot
Number of subjects: 80
Study: 12519109

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted vaginal hysterectomy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Abdominal hysterectomy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Vaginal hysterectomy
Number of subjects: 90
Study: 9686324

Group type: EXPERIMENTAL
Intervention: BT563 (10 mg/d from day 0 until day 12)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 40
Study: 8004363

Group type: EXPERIMENTAL
Intervention: ket 1 mg/kg + mid 0.1 mg/kg, max. 5 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: ket 1 mg/kg + mid 0.05 mg/kg, max. 2.5 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: ket 0.75 mg/kg + mid 0.1 mg/kg, max. 5 mg
Number of subjects: 33
Study: 2806201

Group type: EXPERIMENTAL
Intervention: 100 ml dairy cream and 23 g protein (casein)
Number of subjects: 15

Group type: COMPARATOR
Intervention: 100 ml dairy cream
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 23 g casein
Number of subjects: 15
Study: 1105777

Group type: EXPERIMENTAL
Intervention: Genuine roentgen radiation treatment
Number of subjects: 104

Group type: COMPARATOR
Intervention: Sham treatment (placebo)
Number of subjects: 104
Study: 28718904

Group type: EXPERIMENTAL
Intervention: Autologous serum drops
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional artificial tears
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 60
Study: 27505329

Group type: EXPERIMENTAL
Intervention: Screening arm: invitation to clinical examination followed by ambulant ECG recording
Number of subjects: 2443

Group type: COMPARATOR
Intervention: Control group (non-participants)
Number of subjects: 2443
Study: 25908360

Group type: EXPERIMENTAL
Intervention: Nomogram for calculating maximum dose of local anaesthetic
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard mathematical techniques for drafting the nomogram
Number of subjects: 0
Study: 23142857

Group type: EXPERIMENTAL
Intervention: Peer education intervention (PEI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 0
Study: 20431490

Group type: EXPERIMENTAL
Intervention: Radiographic assessment by Observer A
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Radiographic assessment by Observer B
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intraobserver reproducibility for Observer A
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intraobserver reproducibility for Observer B
Number of subjects: 80
Study: 18371578

Group type: EXPERIMENTAL
Intervention: Explanatory models of addictive behaviour among native German and Russian-German youth
Number of subjects: 268

Group type: COMPARATOR
Intervention: Explanatory models of addictive behaviour among Turkish youth
Number of subjects: 268
Study: 16755298

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (lap), 452 patients
Number of subjects: 682

Group type: COMPARATOR
Intervention: Open procedure (open), 230 patients
Number of subjects: 682
Study: 14629776

Group type: EXPERIMENTAL
Intervention: Community-based strategies to develop broader family and community supports for recent mothers.
Number of subjects: 5740

Group type: EXPERIMENTAL
Intervention: Primary care strategies to increase practitioners' response to maternal depression and physical health issues.
Number of subjects: 5740

Group type: COMPARATOR
Intervention: Comparison arm (control group).
Number of subjects: 5740
Study: 11029598

Group type: EXPERIMENTAL
Intervention: ACE-inhibition (quinapril, 10 mg day-1)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 9313070

Group type: EXPERIMENTAL
Intervention: Early amniocentesis
Number of subjects: 5085

Group type: COMPARATOR
Intervention: Standard amniocentesis
Number of subjects: 5085
Study: 8393028

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 2 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 4 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 8 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3772621

Group type: EXPERIMENTAL
Intervention: Seminar method
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study: 2492746

Group type: EXPERIMENTAL
Intervention: + (milk containing lactose)
Number of subjects: 15

Group type: COMPARATOR
Intervention: - (milk containing glucose)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Water solution
Number of subjects: 15
Study: 30947938

Group type: EXPERIMENTAL
Intervention: Everolimus-Eluting Stent (EES)
Number of subjects: 2667

Group type: COMPARATOR
Intervention: Sirolimus-Eluting Stent (SES)
Number of subjects: 2667
Study: 27632067

Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (HA)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Corticosteroid (CS)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Lactated Ringer Solution (LR; placebo)
Number of subjects: 102
Study: 26193719

Group type: EXPERIMENTAL
Intervention: He-wei Jie-gu decoction and Caltrate D
Number of subjects: 90

Group type: COMPARATOR
Intervention: Caltrate D
Number of subjects: 90
Study: 24192120

Group type: EXPERIMENTAL
Intervention: Calcium channel blocker (CCB)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blocker (ARB)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Angiotensin‐converting enzyme inhibitor (ACEI)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Control group (valsartan or amlodipine)
Number of subjects: 265